Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. EXACT Therapeutics AS
  6. News
  7. Summary
    EXTX   NO0010852213

EXACT THERAPEUTICS AS

(EXTX)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EXACT Therapeutics AS: Share Capital Increase

06/07/2021 | 03:57am EST
Oslo, 7 June 2021 - The Board of Directors of EXACT Therapeutics AS (the
"Company") has resolved on June 4th 2021 to increase the share capital of the
Company by NOK 97.668 through the issuance of 24,427 new shares.
 
The new shares are issued pursuant to the authorisation provided to the Board of
Directors at the Annual General Meeting in 2020, for the purpose of issuing
shares under the Company's restricted stock unit (RSU) program to its board
members. The shares are issued at a price of NOK 20.804 per share, which equals
the market price of the share in the last private placement of the Company.
 
Following the share capital increase, the Company will have a share capital of
NOK 119,968.668 divided into 29,992,167 shares, each with a nominal value of NOK
0.004.
 
DISCLOSURE REGULATION
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.
 

About EXACT-Tx
EXACT-Tx is a clinical stage Norwegian biotech company developing a technology
platform for targeted therapeutic enhancement - Acoustic Cluster Therapy (ACT®).
ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug
enhancement - with the potential to significantly amplify the clinical utility
of a wide range of therapeutic agents across a multitude of indications
including within oncology (chemotherapy, immunotherapy), infectious diseases,
and neurological conditions. www.exact-tx.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange

All news about EXACT THERAPEUTICS AS
12/03Exact Therapeutics AS Minutes From Extraordinary General Meeting - Appointment Of New B..
AQ
12/03EXACT Therapeutics AS Announces Board Changes
CI
11/25To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING
AQ
10/19EXACT THERAPEUTICS : Announces changes to the management team
AQ
10/19EXACT Therapeutics AS Announces Executive Changes
CI
10/19EXACT Therapeutics AS Announces Changes to the Management Team
CI
09/22EXACT THERAPEUTICS : announces interim results for first half 2021
AQ
09/22Exact Therapeutics as Reports Earnings Results for the Half Year Ended June 30, 2021
CI
06/30EXACT THERAPEUTICS : Share capital increase registered
AQ
06/07EXACT THERAPEUTICS AS : Primary insider notices
AQ
More news
Financials
Sales 2020 - - -
Net income 2020 -33,1 M -3,60 M -3,60 M
Net cash 2020 160 M 17,4 M 17,4 M
P/E ratio 2020 -26,7x
Yield 2020 -
Capitalization 521 M 56,8 M 56,8 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float 33,9%
Chart EXACT THERAPEUTICS AS
Duration : Period :
EXACT Therapeutics AS Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Dominic Michael Moreland Chief Executive & Financial Officer
Masha Paule Nathalie Str°mme Executive Chairman
Andrew John Healey Chief Scientific Officer
Spiros Kotopoulis Chief Technology Officer
Hilary McElwaine-Johnn Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
EXACT THERAPEUTICS AS-41.02%57
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298